EPFL
Protein modifications key influencers in neurodegenerative diseases
Research
EPFL
Exploring the post-translational modifications of a key protein in Parkinson's disease, researchers at EPFL and USC uncover potential pathways for future therapies in neurodegenerative diseases in general.
A “quantum leap” at room temperature
Research
EPFL
EPFL scientists have achieved a milestone by controlling quantum phenomena at room temperature.
EPFL startups forge ahead despite the economic headwinds
TechTransfer
EPFL
EPFL startups raised CHF 470 million in 2023 – a record figure if we exclude 2021, an exceptional year with three IPOs. A total of 23 startups were created in 2023, and over a third of them by women.
GPT-3 transforms chemical research
Research
EPFL
Scientists at EPFL demonstrate how GPT-3 can transform chemical analysis, making it faster and more user-friendly.
A machine learning framework that encodes images like a retina
Research
EPFL
EPFL researchers have developed a machine learning approach to compressing image data with greater accuracy than learning-free computation methods, with applications for retinal implants and other sensory prostheses.
“Genomic time machine” reveals secrets of our DNA
Research
EPFL
EPFL researchers reveal a novel method to uncover bits of our genetic blueprint that come from ancient genetic parasites, offering fresh insights into human evolution and health.
Page 25 of 103